Colgate-Palmolive (NYSE:CL – Get Rating) saw some unusual options trading on Tuesday. Traders acquired 25,035 put options on the company. This represents an increase of 376% compared to the typical daily volume of 5,259 put options.
Institutional Investors Weigh In On Colgate-Palmolive
A number of institutional investors and hedge funds have recently bought and sold shares of CL. TCI Wealth Advisors Inc. raised its holdings in Colgate-Palmolive by 76.0% in the 2nd quarter. TCI Wealth Advisors Inc. now owns 315 shares of the company’s stock valued at $25,000 after acquiring an additional 136 shares during the last quarter. Better Money Decisions LLC acquired a new position in Colgate-Palmolive in the 2nd quarter valued at $25,000. Verity Asset Management Inc. acquired a new position in Colgate-Palmolive in the 1st quarter valued at $29,000. Hallmark Capital Management Inc. increased its holdings in shares of Colgate-Palmolive by 158.2% during the 3rd quarter. Hallmark Capital Management Inc. now owns 408 shares of the company’s stock worth $29,000 after buying an additional 250 shares during the last quarter. Finally, Investors Asset Management of Georgia Inc. GA ADV acquired a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $35,000. Hedge funds and other institutional investors own 77.63% of the company’s stock.
Colgate-Palmolive Price Performance
CL stock opened at $78.31 on Wednesday. Colgate-Palmolive has a 1 year low of $67.84 and a 1 year high of $85.04. The company has a debt-to-equity ratio of 7.81, a quick ratio of 0.71 and a current ratio of 1.17. The stock’s 50 day moving average price is $77.18 and its 200 day moving average price is $76.97. The firm has a market cap of $65.41 billion, a P/E ratio of 34.05, a PEG ratio of 6.98 and a beta of 0.51.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on CL shares. UBS Group cut their target price on Colgate-Palmolive from $90.00 to $80.00 in a research report on Thursday, October 13th. Credit Suisse Group cut their target price on Colgate-Palmolive from $88.00 to $85.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 18th. Barclays lifted their target price on Colgate-Palmolive from $72.00 to $76.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 1st. Deutsche Bank Aktiengesellschaft lifted their target price on Colgate-Palmolive from $85.00 to $87.00 and gave the stock a “buy” rating in a research report on Tuesday, December 6th. Finally, Wolfe Research started coverage on Colgate-Palmolive in a research report on Monday, November 21st. They set a “market perform” rating on the stock. Eight analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $83.00.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
- Get a free copy of the StockNews.com research report on Colgate-Palmolive (CL)
- Is Salesforce’s New Rally The Beginning Of A Big Uptrend?
- Can Lockheed Martin Corporation Hit Another All-Time High in Q1?
- Marathon Digital Holdings, Inc: Slow And Steady Wins The Race
- The WD-40 Company Is Ready To Rebound, But Will It?
- Skechers Not Nike Is The Sneaker Stock to Own for 2023
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.